CARLSBAD & LA JOLLA, Calif.--(BUSINESS WIRE)--Life Technologies Corporation (NASDAQ: LIFE) and the University of California at San Diego Moores Cancer Center today announced a partnership to use SOLiD™ 4 genomic analysis technology in a research program to study chronic lymphocytic leukemia (CLL), a cancer of the white blood cells. The CLL research is made possible by funding from the National Institutes of Health and will enable scientists to survey the whole transcriptomes of 96 CLL tumor samples for potential biomarkers.
